Format

Send to:

Choose Destination
See comment in PubMed Commons below
Prostate Cancer Prostatic Dis. 2008;11(3):247-51. doi: 10.1038/pcan.2008.7. Epub 2008 Feb 12.

Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.

Author information

  • 1Department of Urology, University of Alabama, Birmingham, AL 35294, USA. jan.colli@ccc.uab.edu

Abstract

We hypothesized that prostate cancer screening and availability of urologists among states may be associated with reduced prostate cancer mortality in the United States. To test this hypothesis, state-specific prostate cancer mortality rates for white males were compared to urologist population densities and prostate-specific antigen (PSA) screening rates on a state-by-state basis. The urologist population density was calculated by dividing the number of urologists per state by the population. We found that prostate cancer mortality rates correlated inversely with urologist population densities (P<0.01) and PSA screening (P<0.01) suggesting that screening and treatment reduce prostate cancer mortality.

PMID:
18268527
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk